<DOC>
	<DOC>NCT00584714</DOC>
	<brief_summary>The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).</brief_summary>
	<brief_title>Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients enrolled in Protocol 127014 who 1. Were enrolled in Stratum 1 2. Did not undergo angiography during study evaluation 3. Did not have a clinical oucome during the initial 6 month followup period as described in Protocol 127014.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>ultrasound</keyword>
	<keyword>perfusion</keyword>
	<keyword>SPECT</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>chest pain</keyword>
	<keyword>low probability</keyword>
	<keyword>angiography</keyword>
	<keyword>clinical outcomes</keyword>
</DOC>